AI search tool helps physicians to find the perfect clinical trials for their patients
A newly developed search tool uses AI to understand patient needs and reccomend the best clinical trials for their treatment, whilst keeping physicians centered in the process to ensure the best care.
myTomorrows, a company with a missions to connect patients, physicians and biopharma companies to reach solutions that benefit everyone, have launched a clinical trial database search tool to help patients.
The tool, TrialSearch AI, is a physician-focused, pre-screening clinical trial search tool that uses AI technology to assist physicians in identifying clinical trials or expanded access programmes that could be beneficial for their patients.
In normal practice, a physician will go through a patients entire medical background, and compare this to a myriad of specific clinical trial criteria – a time consuming activity. TrialSearch AI provides a much faster, more efficient way of doing this by running a side by side comparison of patient medical history and publicly available clinical trial eligibility criteria or expanded access programme criteria from programmes around the world. Once the tool has run the search, it requests that the physician complete some further manual checks, and whether a pre-approval option is applicable for particular patients.
The tool can reduce the time physicians spend manually searching for trials by up to 90%, whilst still maintaining the layer of human decision making to give patients the best opportunity for personalised care.
The tools should be able to help patients with unmet needs and be especially useful for those with rare diseases.
“Our team of researchers and developers designed TrialSearch AI to bring greater speed, transparency, and accuracy to the complex, time-consuming task of manually searching for clinical trials. As a physician who cared for patients diagnosed with cancer, I know first-hand the importance of providing actionable information that can help physicians, patients, and caregivers discover and access potentially life-saving treatments,” commented Michel van Harten, CEO of myTomorrows.
Related News
-
News Pharma CEOs write open letter calling suppliers to commit to sustainability
Several big pharma companies have added their names to a letter challenging suppliers in the healthcare industry to pledge to sustainability targets. -
News Alzheimer's drug donanemab deemed effective in landmark clinical trial
Results from the TRAILBLAZER-ALZ 2 Randomised Clinical Trial into the use of donanemab to treat early symptoms of Alzheimer’s disease have been analysed. -
News Ardena forms partnership with RiboPro to improve mRNA-based therapies
Ardena and RiboPro have formed an alliance to boost their respective skills in manufacturing and producing nanoparticle and mRNA-based therapeutics to improve accessibility to this technology in the biotherapeutic landscape. -
News Humira biosimilars at discounted prices to meet market demand for accessible treatment
Several biosimilars to AbbVie’s monoclonal antibody therapeutic Humira were launched by various pharmaceutical giants this week in the US, with more expected to be released by the end of the year as the patent expires. -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News Women in Pharma: Gearing up for systemic change
In our new monthly series, we interview women from across the pharmaceutical industry and supply chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. -
News Delivering on mRNA-based therapeutics: innovations in applications and packaging
Since the onset of the COVID-19 pandemic, the innovative potential of mRNA vaccines and therapeutics has raised questions regarding their manufacturing, packaging, and storage/transportation. Learn about how the pharmaceutical supply chain is meet... -
News Your Prescription for Marketing Success: Digital Pharma Marketing Toolkit – Free eBook
Download your FREE pharma marketing eBook to learn why it is so important for pharmaceutical marketeers to develop their digital content marketing strategies in order to establish their companies as thought leaders and industry experts.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance